Camille L. Bedrosian - Insider Trading & Ownership
-
Entity
-
Individual
-
Location
-
C/O Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato, CA
-
Summary
-
The estimated net worth of Camille L. Bedrosian is at least $2.31M dollars as of December 3, 2024. Camille L. Bedrosian is the EVP and Chief Medical Officer of Ultragenyx Pharmaceutical Inc. and owns shares of Ultragenyx Pharmaceutical Inc. (RARE) stock worth about $981K. Camille L. Bedrosian is the Chief Medical Officer of Amylyx Pharmaceuticals, Inc. and owns shares of Amylyx Pharmaceuticals, Inc. (AMLX) stock worth about $766K. Camille L. Bedrosian is the Director of Crinetics Pharmaceuticals, Inc. and owns shares of Crinetics Pharmaceuticals, Inc. (CRNX) stock worth about $446K. Camille L. Bedrosian is the Director of RHYTHM PHARMACEUTICALS, INC. and owns shares of RHYTHM PHARMACEUTICALS, INC. (RYTM) stock worth about $117K.
Ownership of Camille L. Bedrosian
Insider Transactions Reported by Camille L. Bedrosian:
* An asterisk sign (*) next to the price indicates that the price is likely invalid.